Quality of life is an important end point in clinical trials, yet there are few quality of life questionnaires for neuroendocrine tumours. Analysis of QLQ-GINET21 scales confirmed appropriate ...
Correspondence to Dr A Hirschmüller, Department of Orthopedics and Trauma Surgery, Medical Center—University of Freiburg, Center for Surgery, Hugstetter Str. 55, Freiburg im Breisgau D-79106, Germany; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback